(ALS, Charcot, Lou Gehrig)
![Acta Neurologica Scandinavica logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/Acta-Neurologica-Scandinavica-logo.webp?fit=300%2C38&ssl=1)
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability
Main results: Treatment of MS patients with Sativex(®) does not negatively impact on driving ability and may improve moderate to ...
![frontiers in Psychiatry](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2020/05/frontiers-in-Psychatry.png?fit=300%2C120&ssl=1)
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Main results: In general, cognitive performance declined mostly in a THC dose-dependent manner, with steady resolution of impairment in the ...
![International Journal of Legal Medicine logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/International-Journal-of-Legal-Medicine-logo.jpg?fit=300%2C83&ssl=1)
Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a tobacco substitute
Main results: All urine samples tested negative by three immunochemical assays for detection of cannabis use. This is an important ...
![Forensic Sciences Research logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/Forensic-Sciences-Research-logo.png?fit=300%2C76&ssl=1)
Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
Main results: No significant impact on driving ability was found after smoking CBD-rich marijuana. No effects on vital signs were ...
![Psychopharmacology logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2020/10/Psychopharmacology-logo.png?fit=300%2C51&ssl=1)
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Main results: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some ...
![Drug Testing and Analysis logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/Drug-Testing-and-Analysis-logo.png?fit=300%2C185&ssl=1)
Orally administered cannabidiol (CBD) does not produce false‐positive tests for THC on the Securetec DrugWipe® 5S or Dräger Drug Test® 5000
Main results: Orally administered CBD does not appear to produce false-positive (or true-positive) tests for THC on the DW-5S and ...
![Accident Analysis & Prevention logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/Accident-Analysis-Prevention-logo.png?fit=300%2C71&ssl=1)
Simulated driving performance among daily and occasional cannabis users
Main results: Occasional users had a similar drug effect as daily users but lower blood THC. Smoked cannabis led to ...
![Neuroscience & Biobehavioral Reviews logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/10/Neuroscience-Biobehavioral-Reviews-logo.png?fit=300%2C60&ssl=1)
Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Main results: Most driving-related skills are predicted to recover within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg Δ9-THC ...
![Frontiers in Pharmacology logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2020/11/Frontiers-in-Pharmacology-logo2.png?fit=300%2C110&ssl=1)
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Main results: we highlight the possibility that, in addition to neurons, glial changes could help to explain the complex pharmacology ...
![Pharmacology Research & Perspectives logo](https://i0.wp.com/www.86avenue.ch/wp-content/uploads/2021/07/Pharmacology-Research-and-Perspectives.jpg?fit=300%2C47&ssl=1)
Diversity of molecular targets and signaling pathways for CBD
Main results: CBD’s potential as a therapeutic comes from its multiple mechanisms of action. This wide range of pharmacological activity ...